M&A - Badial Verender S.
Form Type: 5
Filing Date: 2025-02-14
Corporate Action: Acquisition
Type: New
Accession Number: 000141588925004111
Filing Summary: On February 14, 2025, Badial Verender S., Chief Financial Officer of Zura Bio Ltd, reported various transactions involving Class A Ordinary Shares and warrants. The document indicates that Class A ordinary shares were distributed to Badial by JATT Ventures L.P. for no additional consideration. Additionally, the reported warrants were exchanged for Class A ordinary shares pursuant to an exchange offer from the issuer. Each warrant holder received 0.30 ordinary shares for each warrant tendered, with no fractional shares issued during the exchange. Any fractional shares were compensated in cash, without interest. The document references the S-4 filing by the issuer on July 12, 2024, for further details of the exchange offer.
Document Link: View Document
Additional details:
Class A Ordinary Shares: distributed by JATT Ventures L.P.
Warrants Exchange Rate: 0.30 Ordinary Shares for each warrant
No Fractional Shares: no fractional Ordinary Shares were issued
Fractional Shares Payment: paid in cash (without interest)
Exchange Offer Reference: S-4 filed on July 12, 2024
Comments
No comments yet. Be the first to comment!